| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.008 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |